期刊文献+

腹型肥胖B型钠尿肽水平及其对评估慢性心功能不全的影响 被引量:2

Level of B-type Natriuretic Peptide and Its Impact on Evaluating of Chronic Ventricular Dysfunction in Patients with Abdominal Obesity
暂未订购
导出
摘要 【目的】探讨腹型肥胖患者血浆B型钠尿肽(BNP)水平及其对评估慢性心功能不全的影响。【方法】本院内科收治的慢性心功能不全患者158例,根据腰臀比(WHR)分为两组:腹型肥胖组(男性WHR≥0.85或女性WHR≥0.8)62例和非腹型肥胖组(男性WHR〈0.85或女性WHR〈0.8)96例;ELISA法测定血浆BNP浓度;超声心动图测定舒张末期室间隔厚度(IVST)、左室后壁厚度(LVPW)、左室舒张末内径(LVEDd)、舒张早期速度峰值(E)与舒张晚期速度峰值(A)的比值(E/A)和左室射血分数(LVEF);比较两组血浆BNP水平及超声心动图测量结果、以BNP100pg/mL为切点评估心脏功能时的诊断敏感性;将血浆BNP测定值进行对数转换后,与BMI进行线性回归分析。【结果】腹型肥胖纽中血浆BNP水平(306.88±225.46pg/mL)明显低于非腹型肥胖组[(548.31±353.22)pg/mL,P〈0.051;以BNP100pg/mL为切点,对心脏舒张功能不全的诊断敏感性腹型肥胖组(83.3%)低于非腹型肥胖组(93.1%),对心脏收缩功能不全的诊断敏感性腹型肥胖组(90.0%)低于非腹型肥胖组(97.4%),但降低程度均无显著性差异(P〉0.05);LogBNP与BMI之间存在负相关(r=-0.276,P〈0.05)。【结论】腹型肥胖会影响血浆BNP水平,BMI与血浆BNP呈负相关,对腹型肥胖患者进行心功能评价时应考虑‘该因素的影响。 [Objective] To explore the level of B-type natriuretic peptide(BNP) and its impact on evaluating chronic ventricular dysfunction in patients with abdominal obesity. [Methods] Totally 158 patients with chronic ventricular dysfunction were enrolled in this study. According to waist/hip ratio(WHR), patients were divided into abdominal obesity group(male WHR≥0.85 or female WHR≥0.8, n=62) and non-abdominal obesity group (male WHR〈0. 85 or female WHR〈0.8, n =96). The plasma concentration of BNP was measured by ELISA. Interventricular septum thickness at enddiastole(IVST), left ventricular posterior wall(LVPW), left ventricular end-diastolic dimension(LVEDd), E/A ratio and left ventricular ejection fraction(LVEF) were measured by echocardiography. Concentration of BNP and parameters measured by echocardiography were compared between two groups. Sensitivity of cutoff 100pg/ml of BNP to diagnose ventricular function was also compared. Linear regression analysis was used to investigate the relationship between Log BNP and BMI. [Results] Plasma concentration of BNP in the abdominal obesity group(306.88± 225.46pg/mL) was obviously lower than that in the non-abdominal obesity group(548.31 ± 353.22pg/mL) ( P 〈0. 05). BNP100pg/mL was set as the cutoff to evaluate ventricular function. Sensitivity of determining diastolic dysfunction in the abdominal obesity group(83.3 % ) was lower than that in the non-abdominal obesity group(93.1% ). Sensitivity of determining systolic dysfunction in the abdominal obesity group (90.0%) was lower than that in non-abdominal obesity group (97.4%). Log BNP was reversely correlated with BMI(r= -0. 276, P 〈0. 05). [Conclusion] Plasma concentration of BNP can be affected by abdominal obesity. BMI is reversely correlated with plasma BNP. The influence of abdominal obesity must be considered as heart function is assessed.
出处 《医学临床研究》 CAS 2011年第4期640-643,共4页 Journal of Clinical Research
关键词 肥胖症 心钠素 心力衰竭 充血性 obesity atrial natriuretic factor heart failure,congestive
  • 相关文献

参考文献13

  • 1Clerico A,Emdin M.Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides:a review[J].Clin Chem,2004,50:33-50.
  • 2Mehra MR,Uber PA,Park M,et al.Obesity and suppressed B-type natriuretic peptide levels in heart failure[J].J Am Coll Cardiol,2004,43(9):1590-1595.
  • 3Dandona P,Aljada A,Chaudhuri A,et al.Metabolic syndrome:a comprehensive perspective based on interactions between obesity,diabetes and inflammation[J].Circulation,2005,111:1448-1454.
  • 4European study group on diastolic heart failure.How to diagnose diastolic heart failure[J].Eur heart J,1998,19:990-1003.
  • 5Maisel AS,Koon J,Krishnaswamy P,et al.Utility of B-natriuretic peptide as a rapid,point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction[J].Am Heart J,2001,141:367-374.
  • 6Lubien E,DeMaria A,Krishnaswamy P,et al.Utility of B-natriuretic peptide in detecting diastolic dysfunction:comparison with Doppler velocity recordings[J].Circulation,2002,105:595-601.
  • 7Fox CS,Massaro JM,Hoffmann U,et al.Abdominal visceral and subcutaneous adipose tissue compartments:association with metabolic risk factors in the Framingham heart study[J].Circulation,2007,116:39-48.
  • 8De Simone G,Palmieri V,Bella JN,et al.Association of left ventricular hypertrophy with metabolic risk factors:the HyperGEN study[J].J Hypertens,2002,20(2):323-331.
  • 9田志强,陈静,闫振成,倪银星,赵志钢,金婕,罗志丹,刘浩宇,祝之明.代谢综合征患者腹内脂肪与心血管损害的关系[J].解放军医学杂志,2005,30(8):687-689. 被引量:28
  • 10Karason K,Sjostrom L,Wallentin I,et al.Impact of blood pressure and insulin on the relationship between body fat and left ventricular structure[J].Eur Heart J,2003,24(16):1500-1505.

二级参考文献3

共引文献27

同被引文献21

  • 1邵咏红,赖玉琼,林爱珍,孔耀中.脑钠肽对血液透析患者心功能不全的诊断价值[J].第一军医大学学报,2005,25(7):892-894. 被引量:15
  • 2张之玮,杨普荣,徐应军,史丽萍.B型利钠肽在2型糖尿病舒张性心功能不全患者诊断中的临床应用[J].中国煤炭工业医学杂志,2007,10(3):270-271. 被引量:1
  • 3吴利云,郑道国,徐群威,狄永康,张美素.血浆B型利钠肽水平对老年心功能不全患者早期诊断价值[J].中国医师杂志,2007,9(4):546-547. 被引量:1
  • 4Targher G,Arcaro G.Non-alcoholic fatty liver disease and increased risk of cardiovascular disease[J].Atherosclerosis,2007,191(2):235-240.
  • 5Day CP,Saksena S.Non-alcoholic steatohepatitis:definitions and pathogenesis[J].J Gastroenterol Hepatol,2002,17 Suppl 3:S377-S384.
  • 6Choi SY,Kim D,Kim HJ,et al.The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans[J].Am J Gastroenterol,2009,104(8):1953-1960.
  • 7DeFronzo RA.Insulin resistance,lipotoxicity,type 2 diabetes and atherosclerosis:the missing links[J].The Claude Bernard Lecture,2009,Diabetologia,2010,53(7):1270-1287.
  • 8Czyzewska M,Wolska A,Cwiklińska A,et al.Disturbances of lipoprotein metabolism in metabolic syndrome[J].Postepy Hig Med Dosw (Online),2010,64:1-10.
  • 9Kaneto H,Katakami N,Matsuhisa M,et al.Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis[J].Mediators Inflamm,2010,2010:453892.
  • 10Casco VH,Veinot JP,Kuroski de Bold ML,et al.Natriuretic peptide system gene expression in human coronary arteries[J].J Histochem Cytochem,2002,50(6):799-809.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部